|
Theranostics 2018
A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancerDOI: 10.7150/thno.22901 Keywords: non-small cell lung cancer (NSCLC), quantitative proteomics, deubiquitinase, USP9X, TTK Abstract: The X-linked deubiquitinase, USP9X, is implicated in multiple cancers by targeting various substrates. Increased expression of USP9X is observed in non-small-cell lung cancer (NSCLC) and is correlated with poor prognosis. However, the molecular mechanism for USP9X regulation of tumor cell survival and tumorigenesis in NSCLC is less defined.
|